Skip to content
★ Sign in to follow
AL

Ayabudge LLC

Related company / holding
Humacyte, Inc.
Total declarations
13
Company
1
▲ Purchases (1 ops.)
€13.0M
▼ Sales (11 ops.)
€34.3M

Latest filing published 21 Aug 2023 for Humacyte, Inc., €2.1M.

Filing timeline

BuySale
Ayabudge LLC

Insider track record

Disclosed buys
1
Disclosed sells
11
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Ayabudge LLC: trading record in brief

Ayabudge LLC is a declared insider of Humacyte, Inc., with filings sourced from SEC (Form 4). In total, 13 filings cover trades dated from 26 August 2021 to 21 August 2023.

In open-market terms, that means 1 purchase worth €13.0M on one side and 11 sales worth €34.3M on the other. Sales outweigh purchases by €21.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant. So far in 2023, the count stands at no purchases and 6 sales.

The newest entry dates from 21 August 2023: an open-market sale of €2.1M, in Humacyte, Inc. The latest purchase dates back some time: it was published 1,900 days ago, on 27 August 2021. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Ayabudge LLC

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.

    Same trade as the filing by Laura E. Niklason, counted once

    2M USD21SEC
    626,979 shares@ US$3.5712.4% of flowCommon StockSEC:0001818382-23-000119:1
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.

    Same trade as the filing by Laura E. Niklason, counted once

    2M USD21SEC
    602,443 shares@ US$3.3911.3% of flowCommon StockSEC:0001818382-23-000119:2
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.

    Same trade as the filing by Brady W. Dougan, counted once

    2M USD18SEC
    570,174 shares@ US$3.686.6% of flowCommon StockSEC:0001818382-23-000119:0
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.

    Same trade as the filing by Brady W. Dougan, counted once

    2M USD17SEC
    500,000 shares@ US$3.11754.8% of flowCommon StockSEC:0001818382-23-000081:0
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.
    13M USD21SEC
    4,875,000 shares@ US$2.6040.0% of flowCommon StockSEC:0001818382-23-000047:0
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.

    Same trade as the filing by Laura E. Niklason, counted once

    7M USD19SEC
    2,625,000 shares@ US$2.7522.9% of flowCommon StockSEC:0001104659-23-065543:0
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.

    Same trade as the filing by Laura E. Niklason, counted once

    606,031 USD17SEC
    239,538 shares@ US$2.531.9% of flowCommon StockSEC:0001818382-22-000219:0
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.

    Same trade as the filing by Laura E. Niklason, counted once

    762,599 USD20SEC
    276,304 shares@ US$2.764.3% of flowCommon StockSEC:0001818382-22-000209:1
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.

    Same trade as the filing by Laura E. Niklason, counted once

    245,710 USD20SEC
    93,426 shares@ US$2.631.4% of flowCommon StockSEC:0001818382-22-000209:2
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.

    Same trade as the filing by Laura E. Niklason, counted once

    937,200 USD17SEC
    330,000 shares@ US$2.843.0% of flowCommon StockSEC:0001818382-22-000209:0
  • ▼
    Related company / holdingExecutivesHumacyte, Inc.

    Same trade as the filing by Laura E. Niklason, counted once

    6M USD19SEC
    1,522,500 shares@ US$4.0020.7% of flowCommon StockSEC:0001818382-22-000159:0
  • ▲
    Related company / holdingExecutivesHumacyte, Inc.
    15M USD0SEC
    1,522,500 shares@ US$10.00Common StockSEC:0001104659-21-110538:1
    Canonical exit: 24 Nov 2021 (T+90)
  • ◆
    Related company / holdingExecutivesHumacyte, Inc.
    0SEC
    18,930,004 sharesCommon StockSEC:0001104659-21-110538:0

13 of 3 declarations